| 黄关庆.舒利迭辅助治疗支气管哮喘患者的价值探析[J].实用中西医结合临床,2020,20(10): |
| 舒利迭辅助治疗支气管哮喘患者的价值探析 |
| Value of Seretide in the Adjuvant Treatment of Bronchial Asthma |
| 投稿时间：2020-06-02 修订日期：2020-07-01 |
| DOI： |
| 中文关键词: 舒利迭 痰液炎性标志物 沙丁胺醇 支气管哮喘 |
| 英文关键词: Seretide sputum inflammatory markers salbutamol bronchial asthma |
| 基金项目: |
|
| 摘要点击次数: 610 |
| 全文下载次数: 171 |
| 中文摘要: |
| 目的 探析舒利迭辅助治疗支气管哮喘患者的价值。方法 选取我院2019年2月至2020年2月支气管哮喘患者共107例,按照随机数字表法分为对照组(n=53,沙丁胺醇治疗)和观察组(n=54,在对照组的基础上加用舒利迭治疗)。1周后,对比两组治疗效果、肺通气功能及痰液炎性标志物。结果 观察组治疗总有效率94.44%高于对照组73.58%(P<0.05)；治疗后,观察组FEV1、FVC、PEF均高于对照组(P<0.05)；治疗后,观察组TNF-α、ECP、IL-5水平均低于对照组(P<0.05)。结论 使用舒利迭辅助治疗支气管哮喘可提高治疗有效率,降低炎性因子水平,改善患者肺通气功能,值得进一步推广。 |
| 英文摘要: |
| Objective To explore the value of seretide in the adjuvant treatment of bronchial asthma patients.Methods A total of 107 patients with bronchial asthma in our hospital from February 2019 to February 2020 were selected and divided into control group (n=53, salbutamol treatment) and observation group (n=54, Seretide treatment was added on the basis of control group) according to random number table method.After 1 week, the therapeutic effect, pulmonary ventilation function and sputum inflammatory markers were compared between the two groups.Results The total effective rate of the observation group was 94.44% higher than 73.58% of the control group (P<0.05); after treatment, FEV1, FVC and PEF in the observation group were higher than those in the control group (P<0.05); after treatment, the levels of TNF-a, ECP and IL-5 in the observation group were lower than those in the control group (P<0.05).Conclusion Seretide adjuvant treatment of bronchial asthma can improve the treatment efficiency, reduce the level of inflammatory factors, and improve the lung ventilation function of patients, which is worthy of further promotion. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
